Horowitz Limited Partnership Viii - Net Worth and Insider Trading
Horowitz Limited Partnership Viii Net Worth
The estimated net worth of Horowitz Limited Partnership Viii is at least $95 Million dollars as of 2024-11-13. Horowitz Limited Partnership Viii is the 10% Owner of Tarsus Pharmaceuticals Inc and owns about 1,987,105 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $95 Million. Details can be seen in Horowitz Limited Partnership Viii's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Horowitz Limited Partnership Viii has not made any transactions after 2020-10-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Horowitz Limited Partnership Viii
Horowitz Limited Partnership Viii Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Horowitz Limited Partnership Viii owns 1 companies in total, including Tarsus Pharmaceuticals Inc (TARS) .
Insider Ownership Summary of Horowitz Limited Partnership Viii
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2020-10-20 | 10 percent owner |
Horowitz Limited Partnership Viii Latest Holdings Summary
Horowitz Limited Partnership Viii currently owns a total of 1 stock. Horowitz Limited Partnership Viii owns 1,987,105 shares of Tarsus Pharmaceuticals Inc (TARS) as of October 20, 2020, with a value of $95 Million.
Latest Holdings of Horowitz Limited Partnership Viii
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2020-10-20 | 1,987,105 | 47.59 | 94,566,327 |
Holding Weightings of Horowitz Limited Partnership Viii
Horowitz Limited Partnership Viii Form 4 Trading Tracker
According to the SEC Form 4 filings, Horowitz Limited Partnership Viii has made a total of 1 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the acquisition of 184,375 shares on October 20, 2020, which cost Horowitz Limited Partnership Viii around $3 Million.
Insider Trading History of Horowitz Limited Partnership Viii
- 1
Horowitz Limited Partnership Viii Trading Performance
GuruFocus tracks the stock performance after each of Horowitz Limited Partnership Viii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Horowitz Limited Partnership Viii is 92.93%. GuruFocus also compares Horowitz Limited Partnership Viii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Horowitz Limited Partnership Viii within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Horowitz Limited Partnership Viii's insider trading performs compared to the benchmark.
Performance of Horowitz Limited Partnership Viii
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.44 | | | | | |
| Relative Return to S&P 500(%) | 5.12 | | | | | |
Horowitz Limited Partnership Viii Ownership Network
Ownership Network List of Horowitz Limited Partnership Viii
Ownership Network Relation of Horowitz Limited Partnership Viii
Horowitz Limited Partnership Viii Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Horowitz Limited Partnership Viii is the 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Horowitz Limited Partnership Viii made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 231,415 shares made by Bobak R. Azamian , a net sale of 11,909 shares made by Aziz Mottiwala , and a net sale of 12,792 shares made by Bryan Wahl .
In summary, during the past 3 months, insiders sold 0 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,965 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 312,459 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Horowitz Limited Partnership Viii Mailing Address
Above is the net worth, insider trading, and ownership report for Horowitz Limited Partnership Viii. You might contact Horowitz Limited Partnership Viii via mailing address: 5030 Campus Drive, Suite A, Newport Beach Ca 92660.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
